Related references
Note: Only part of the references are listed.In vivo YY1 knockdown effects on genomic imprinting
Joomyeong Kim et al.
HUMAN MOLECULAR GENETICS (2008)
p16INK4a promoter hypermethylation in oral scrapings of oral squamous cell carcinoma risk patients
Maria Teresa Ruesga et al.
CANCER LETTERS (2007)
The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia
Shuchi Agrawal et al.
BLOOD (2007)
Polycomb recruitment to DNA in vivo by the YY1 REPO domain
Frank H. Wilkinson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Polycomb silencers control cell fate, development and cancer
Anke Sparmann et al.
NATURE REVIEWS CANCER (2006)
Association of GSTP1 CpG islands hypermethylation with poor prognosis in human breast cancers
Takashi Arai et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia
A. Scardocci et al.
BRITISH JOURNAL OF CANCER (2006)
Hypermethylation of hMLH1, HPP1, p14ARF, p16INK4A and APC in primary adenocarcinomas of the small bowel
Bjoern L. D. M. Bruecher et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Control of developmental regulator's by polycomb in human embryonic stem cells
TI Lee et al.
CELL (2006)
Epigenetic modulation of tumor suppressor CCAAT/Enhancer binding protein a activity in lung cancer
T Tada et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer
RE Banks et al.
CANCER RESEARCH (2006)
Functional role of NF-IL6 beta and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene
JM Wang et al.
NUCLEIC ACIDS RESEARCH (2006)
Promoter methylation reduces C/EBP delta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors
D Tang et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
C/EBPδ is a crucial regulator of pro-apoptotic gene expression during mammary gland involution
M Thangaraju et al.
DEVELOPMENT (2005)
The polycomb group protein enhancer of zeste homolog 2 (EZH2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype
PA Croonquist et al.
ONCOGENE (2005)
Induction of human NF-IL6β by epidermal growth factor is mediated through the p38 signaling pathway and cAMP response element-binding protein activation in a431 cells
JM Wang et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
CCAAT/enhancer-binding protein δ:: A molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells
T Ikezoe et al.
CANCER RESEARCH (2005)
C/EBPδ is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells
DC Sanford et al.
PROSTATE (2005)
C/EBPδ expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation
S Gery et al.
ONCOGENE (2005)
Overexpression and amplification of Aurora-A in hepatocellular carcinoma
YM Jeng et al.
CLINICAL CANCER RESEARCH (2004)
Loss of CCAAT/enhancer binding protein δ promotes chromosomal instability
AM Huang et al.
ONCOGENE (2004)
Stem cells, aging, and cancer: inevitabilities and outcomes
DR Bell et al.
ONCOGENE (2004)
CCAAT/enhancer-binding protein δ contributes to myofibroblast transdifferentiation and renal disease progression
M Takeji et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex
R Cao et al.
MOLECULAR CELL (2004)
Stem cell origin of cancer and differentiation therapy
S Sell
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27
A Kirmizis et al.
GENES & DEVELOPMENT (2004)
CCAAT/enhancer binding protein δ (C/EBPδ) regulation and expression in human mammary epithelial cells:: I.: Loss of function alterations in the C/EBPδ growth inhibitory pathway in breast cancer cell lines
GS Sivko et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Polycomb complexes and silencing mechansims
AH Lund et al.
CURRENT OPINION IN CELL BIOLOGY (2004)
Epigenetic regulation of cellular memory by the polycomb and trithorax group proteins
L Ringrose et al.
ANNUAL REVIEW OF GENETICS (2004)
High α-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma:: Significance of hepatitis virus infection, age, p53 and β-catenin mutations
SY Peng et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
AP Bracken et al.
EMBO JOURNAL (2003)
Functional cooperation of simian virus 40 promoter factor 1 and CCAAT/enhancer-binding protein 8 and 5 in lipopolysaccharide-induced gene activation of IL-10 in mouse macrophages
YW Liu et al.
JOURNAL OF IMMUNOLOGY (2003)
The role of C/EBPβ in mammary gland development and breast cancer
SL Grimm et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2003)
Transcription factor YY1 functions as a PcG protein in vivo
L Atchison et al.
EMBO JOURNAL (2003)
Polycomb, epigenomes, and control of cell identity
V Orlando
CELL (2003)
cAMP-induced interleukin-10 promoter activation depends on CCAAT/enhancer-binding protein expression and monocytic differentiation
S Brenner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Role of histone H3 lysine 27 methylation in polycomb-group silencing
R Cao et al.
SCIENCE (2002)
CCAAT/enhancer-binding proteins: structure, function and regulation
DP Ramji et al.
BIOCHEMICAL JOURNAL (2002)
Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases
GD Kim et al.
EMBO JOURNAL (2002)
CCAAT/enhancer-binding proteins (C/EBP) β and δ activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression
S Gutierrez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
CCAAT/enhancer binding protein-β is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling
SY Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
DNA methylation patterns and epigenetic memory
A Bird
GENES & DEVELOPMENT (2002)
Use of chromatin immunoprecipitation to clone novel E2F target promoters
AS Weinmann et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Differential regulation of macrophage CCAAT-enhancer binding protein isoforms by lipopolysaccharide and cytokines
TS Tengku-Muhammad et al.
CYTOKINE (2000)
Share Paper
